Sources: Anduril is seeking to raise about $4B in a round co-led by Thrive Capital and a16z, which could nearly double the startup's valuation to ~$60B
Context & Ripple Effects
Anduril’s reported target follows a steep financing trajectory: it was discussing a roughly $1.5B raise at a $12.5B-plus valuation in 2024, after having been valued at $4B-$5B in 2021. The company’s reported revenue growth was part of that earlier fundraising narrative.
The proposed round would also build on 2025 talks for a raise at a $28B valuation, shifting the lead-investor group from Founders Fund to Thrive Capital and a16z if completed.
First-order effects
- A $4B round at roughly $60B would give Anduril a substantially larger capital base while setting a new valuation benchmark for the company; for now, both remain reported terms rather than a completed financing.
- Thrive Capital and a16z would become the named co-leads on a major private-company round, concentrating their exposure to Anduril’s next phase of growth.
Second-order effects
- The proposed valuation would raise the reference point for later Anduril financings and for investors assessing comparable late-stage defense-technology opportunities.
- A round of this size could make it harder for smaller companies in the category to compete for late-stage capital unless they can show comparable scale or strategic relevance.
Third-order effects
- If such rounds continue, defense technology may increasingly be financed through a small set of very large private rounds rather than a broad base of mid-sized venture investments.
- The pattern would reinforce frontier-capital concentration: a few firms with access to top-tier investors can fund longer development and deployment cycles, potentially widening the gap with less-capitalized rivals.
The trend: Anduril is part of the broader trend of capital concentrating in a small number of late-stage frontier companies able to raise multibillion-dollar private rounds.